These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6942668)

  • 21. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA DR antigens and gold toxicity.
    Gran JT; Husby G; Thorsby E
    Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gold-induced thrombocytopenia responsive to cyclophosphamide.
    Kozloff M; Votaw M; Penner JA
    South Med J; 1979 Nov; 72(11):1490-2. PubMed ID: 388652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late onset of gold-induced thrombocytopenia. With a practical note on the injections of dimercaprol.
    Stafford BT; Crosby WH
    JAMA; 1978 Jan; 239(1):50-1. PubMed ID: 579236
    [No Abstract]   [Full Text] [Related]  

  • 25. Predictive value of mean platelet volume in gold induced thrombocytopenia.
    Klimiuk PS; Holt PJ; Clague RB; Herod E; Dyer PA
    Ann Rheum Dis; 1987 Jan; 46(1):38-41. PubMed ID: 3813673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antigens and seronegative rheumatoid arthritis.
    Bardin T; Legrand L; Naveau B; Marcelli-Barge A; Debeyre N; Lathrop GM; Poirier JC; Schmid M; Ryckewaert A; Dryll A
    Ann Rheum Dis; 1985 Jan; 44(1):50-3. PubMed ID: 3855618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA DR antigens and disease expression in rheumatoid arthritis.
    Griffin AJ; Wooley P; Panayi GS; Batchelor JR
    Ann Rheum Dis; 1984 Apr; 43(2):218-21. PubMed ID: 6424587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombopenia and chrysotherapy. Apropos of a personal case].
    Levy R; Brochard C; Alterescu R
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):571-2. PubMed ID: 1008380
    [No Abstract]   [Full Text] [Related]  

  • 34. Undesirable effects of gold salts.
    Davis P
    J Rheumatol Suppl; 1979; 5():18-24. PubMed ID: 290813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.
    Wijnands MJ; Allebes WA; Boerbooms AM; van de Putte LB; van Riel PL
    Ann Rheum Dis; 1990 Oct; 49(10):798-800. PubMed ID: 1978639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.
    Tishler M; Caspi D; Gazit E; Yaron M
    Ann Rheum Dis; 1988 Mar; 47(3):215-7. PubMed ID: 2965554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR4 antigen and IgM rheumatoid factors.
    Queirós MV; Sancho MR; Caetano JM
    J Rheumatol; 1982; 9(3):370-3. PubMed ID: 6981703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA studies in IgM rheumatoid-factor-positive arthritis of childhood.
    Clemens LE; Albert E; Ansell BM
    Ann Rheum Dis; 1983 Aug; 42(4):431-4. PubMed ID: 6603824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe hematologic complications of gold salts prescribed in excessive doses. Apropos of 2 cases].
    Riant P; Larget-Piet B; Kuentz M; Rochant H; Albengres E; Chevais M; Tillement JP
    Therapie; 1984; 39(5):555-9. PubMed ID: 6506013
    [No Abstract]   [Full Text] [Related]  

  • 40. Gold-induced thrombocytopenia and response to dimercaprol.
    England JM; Smith DS
    Br Med J; 1972 Jun; 2(5816):748-9. PubMed ID: 5036882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.